Pediatric HIV: The New Frontier

FEBRUARY 2014: DR. SCOTT KELLERMAN

"PEDIATRIC HIV: THE NEW FRONTIER"

Only 35% of HIV exposed infants access diagnosis testing within the first 2 months of life and only 34% of pediatric HIV patients have access to ART - well below the 68% adult ART coverage.  Dr. Scott Kellerman facilitates a discussion on the barriers to adequate pediatric ART therapy, his vision for treating all HIV+ adolescents under the age of 15 and where there are gaps for organisations like World Vision to fill and participate.

Webinar Recording: https://wvi.webex.com/wvi/ldr.php?RCID=4418924a81206aea5df7de3ba43fa5a4

Scott Kellerman, MD, MPH, is global technical lead on HIV & AIDS for MSH